You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lemborexant

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Insomnia, Dementia, Frontotemporal Dementia Trial (Lemborexant 5 MG)

Not yet recruiting
  • Insomnia
  • +2 more
  • Lemborexant 5 MG
  • (no location specified)
Oct 16, 2023

OSA Trial in Pathum Wan (Lemborexant 5 MG Oral Tablet [Dayvigo] Day 1, Lemborexant 5 MG Oral Tablet [Dayvigo] Day 2, Placebo Day

Recruiting
  • OSA
  • Lemborexant 5 MG Oral Tablet [Dayvigo] Day 1
  • +3 more
  • Pathum Wan, Bangkok, Thailand
    Chulalongkorn University
Mar 8, 2023

Alzheimer Trial in Saint Louis (Lemborexant 25 mg, Placebo)

Recruiting
  • Alzheimer Disease
  • Lemborexant 25 mg
  • Placebo
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 16, 2023

Drug Interaction, Analgesics, Opioid Trial in Richmond (Lemborexant, Placebo)

Recruiting
  • Drug Interaction
  • Analgesics, Opioid
  • Lemborexant
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University
Nov 28, 2022

Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in

Recruiting
  • Chronic Insomnia
  • Chronic Pain
  • Lemborexant
  • Surrey, British Columbia, Canada
    Salem Anaesthesia Pain Clinic
Nov 15, 2022

Delayed Sleep Phase Syndrome Trial in Redwood City (Lemborexant, Placebo)

Recruiting
  • Delayed Sleep Phase Syndrome
  • Lemborexant
  • Placebo
  • Redwood City, California
    Stanford Univeristy
Jul 14, 2022

Alcohol Use Disorder Trial in Houston (Lemborexant 10 mg, Naltrexone)

Not yet recruiting
  • Alcohol Use Disorder
  • Houston, Texas
    The Menninger Clinic
Aug 11, 2022

Shift-Work Related Sleep Disturbance Trial in San Francisco (Lemborexant, Placebo)

Recruiting
  • Shift-Work Related Sleep Disturbance
  • Lemborexant
  • Placebo
  • San Francisco, California
    University of California, San Francisco
Apr 19, 2022

Sleep Initiation and Maintenance Disorders Trial in Korea, Republic of (Lemborexant, PBO)

Recruiting
  • Sleep Initiation and Maintenance Disorders
  • Lemborexant
  • PBO
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +8 more
Dec 20, 2022

Safety of DAYVIGO (Lemborexant) Tablets in Insomnia.

Completed
  • Sleep Initiation and Maintenance Disorders
  • Lemborexant
  • Nagoya, Japan
  • +2 more
Apr 4, 2022

Sleep Initiation and Maintenance Disorders Trial in China, Taiwan (Lemborexant, Placebo)

Recruiting
  • Sleep Initiation and Maintenance Disorders
  • Lemborexant
  • Placebo
  • Beijing, Beijing, China
  • +24 more
Feb 1, 2023

Healthy Volunteers Trial in Las Vegas (Lemborexant)

Completed
  • Healthy Volunteers
  • Lemborexant
  • Las Vegas, Nevada
    PPD Phase 1 Clinic
Sep 2, 2021

Insomnia Trial in Japan (Lemborexant (LEM) 5 mg (Z-Drug-mono cohort), Lemborexant (LEM) 5 mg (SUV-mono cohort), Lemborexant

Recruiting
  • Insomnia
  • Lemborexant (LEM) 5 mg (Z-Drug-mono cohort)
  • +3 more
  • Kitakyushu, Fukuoka, Japan
  • +8 more
Oct 2, 2021

Healthy Volunteer Trial in Shanghai (Lemborexant)

Completed
  • Healthy Volunteer
  • Lemborexant
  • Shanghai, China
    Xuhui Central Hospital
Jul 13, 2021

Sleep Apnea, Obstructive, Pulmonary Disease, Chronic Obstructive, Respiration Disorders Trial in United States (Placebo,

Completed
  • Sleep Apnea, Obstructive
  • +2 more
  • Placebo
  • Lemborexant 10 mg
  • Glendale, Arizona
  • +10 more
Feb 15, 2022

Insomnia Trial in United States (LEM 5 mg, LEM 10 mg)

Completed
Has Results
  • Insomnia
  • LEM 5 mg
  • LEM 10 mg
  • Glendale, Arizona
  • +16 more
Mar 17, 2021

Irregular Sleep-Wake Rhythm Disorder Trial in Japan, United Kingdom, United States (Lemborexant 2.5 mg, Lemborexant 5 mg,

Completed
Has Results
  • Irregular Sleep-Wake Rhythm Disorder
  • Lemborexant 2.5 mg
  • +4 more
  • Little Rock, Arkansas
  • +47 more
Apr 14, 2021

Insomnia Disorders Trial in Toronto (Zolpidem tablets, Suvorexant tablets, over-encapsulated, Lemborexant tablets)

Completed
  • Insomnia Disorders
  • Zolpidem tablets
  • +5 more
  • Toronto, Canada
    INC Research Toronto, Inc.
Jun 26, 2020

Hepatic Impairment Trial in Miami, Orlando (Lemborexant)

Completed
Has Results
  • Hepatic Impairment
  • Lemborexant
  • Miami, Florida
  • +1 more
Mar 3, 2020

Renal Impairment Trial in Miami, Orlando (Lemborexant)

Completed
Has Results
  • Renal Impairment
  • Lemborexant
  • Miami, Florida
  • +1 more
Mar 3, 2020

Insomnia Disorder Trial in Atlanta, Crestview Hills (Lemborexant 5 mg, Lemborexant 10 mg, Lemborexant-matched .)

Completed
Has Results
  • Insomnia Disorder
  • Lemborexant 5 mg
  • +3 more
  • Atlanta, Georgia
  • +1 more
Jan 3, 2020

Obstructive Sleep Apnea, Healthy Subjects Trial in United States (Placebo, Lemborexant 10 mg, Lemborexant 25 mg)

Completed
Has Results
  • Obstructive Sleep Apnea
  • Healthy Subjects
  • Placebo
  • +2 more
  • Glendale, Arizona
  • +10 more
Jan 31, 2020

Insomnia Trial in New York, Cincinnati (E2006 1.0 mg, E2006 2.5 mg, E2006 5.0 mg)

Completed
Has Results
  • Insomnia
  • E2006 1.0 mg
  • +10 more
  • New York, New York
  • +1 more
Jan 3, 2020

Healthy Subjects Trial in United States (LEM5, LEM10, ZOL)

Completed
  • Healthy Subjects
  • Atlanta, Georgia
  • +3 more
Jul 31, 2019

Insomnia Trial in Worldwide (Lemborexant, Lemborexant-matched , Zolpidem tartrate)

Completed
Has Results
  • Insomnia
  • Lemborexant
  • +3 more
  • Jasper, Alabama
  • +101 more
Jan 31, 2020